STRATA Skin Sciences to Highlight Excimer Laser Innovations
Introduction
At the upcoming 2026 Fall Clinical Dermatology Conference in Las Vegas, STRATA Skin Sciences, Inc. will present a compelling case series focused on excimer laser phototherapy. This presentation will detail seven illustrative cases that showcase the effectiveness of the 308-nm excimer laser in treating various localized inflammatory and autoimmune skin diseases. The conference is set to take place from October 8-11, 2026.
Significance of Excimer Laser Therapy
CEO Erica Jordan expressed enthusiastic anticipation for the presentation, underscoring the potential of excimer laser phototherapy to bridge gaps where traditional topical therapies fall short. The company’s commitment to personalized and evidence-based treatment approaches aims to enhance patient outcomes significantly. With this presentation, STRATA seeks not only to share findings but also to contribute to an ongoing discourse amongst healthcare providers regarding innovative treatment modalities for complex skin conditions.
Key Findings from the Case Series
The poster presentation titled "Targeted 308-nm Excimer Laser Phototherapy for Localized Inflammatory and Autoimmune Skin Diseases: An Illustrative Case Series" authored by Dr. Suhail Hadi and Dr. Mark F. Lebwohl reveals several critical insights:
- - High Levels of Re-pigmentation: Patients across seven diverse conditions—psoriasis, atopic dermatitis, palmoplantar keratoderma, vitiligo, post-inflammatory hypopigmentation, alopecia areata, and mycosis fungoides—demonstrated significant re-pigmentation. Notably, treatment success was observed across various anatomical sites, including the scalp, face, hands, and feet.
-
Sustained Results: Follow-up data indicated that responses to the therapy persisted for up to two years, with patients reporting no adverse effects except for transient erythema.
-
Alternative for Patients: This excimer laser therapy provided an effective option for individuals who had been previously unresponsive to standard topical treatments, positioning itself as a viable lifeline for those affected by persistent skin issues.
About STRATA Skin Sciences
STRATA Skin Sciences is renowned for its innovative medical technologies aimed at treating dermatologic conditions through non-invasive methods. The company’s product lineup includes the XTRAC excimer laser, VTRAC lamp systems, and TheraClear X Acne Therapy System. STRATA continues to advance its partnership programs that not only facilitate product access but also enhance practitioner engagement in the dermatological community.
Conclusion
As STRATA prepares to showcase its findings at the dermatology conference, the broader implications of excimer laser therapy emerge, particularly regarding its role in personalized medicine for skin diseases. By highlighting case studies that underscore the therapy's effectiveness, STRATA aims to encourage further exploration and adoption of advanced treatment options in practices seeking to improve patient quality of life.
Contact Information
For further details on STRATA Skin Sciences, interested parties can reach out to their media relations via email.